Trial Profile
A phase II study of aganirsen in patients with wet age-related macular degeneration
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Aganirsen (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 29 Jul 2015 New trial record